Innovator ETFs Trust Files New Prospectus for ETF Product
Innovator ETFs Trust updates its prospectus for the Innovator U.S. Equity Ultra Buffer ETF, emphasizing defined outcome strategies for investors.
Innovator ETFs Trust updates prospectus for equity buffer ETF
Innovator ETFs Trust has filed a new prospectus for its Innovator U.S. Equity Buffer ETF, effective November 2, 2026, reflecting its commitment to defined outcome strategies.
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Richard B. Handler, CEO of Jefferies Financial Group, reports stock transactions reflecting estate planning, as detailed in a recent SEC filing.
Brophy Michael Burkes sells 3,084 shares of Natera stock
Brophy Michael Burkes, CFO of Natera, Inc., sold 3,084 shares of common stock, signaling adjustments in executive holdings and compliance in the medical sector.
Glenbrook Capital Management Boosts Stake in SenesTech
Glenbrook Capital Management increases its stake in SenesTech, acquiring 30,000 shares, signaling confidence in the agricultural chemicals sector.
OS Therapies grants stock options to Chief Medical Officer
OS Therapies Inc grants stock options to CMO Robert Petit, highlighting its commitment to key personnel in the competitive pharmaceutical industry.
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Lin Yu-Hsin, CEO of Belite Bio, vests 5,000 shares after meeting performance criteria, highlighting executive compensation trends in the pharmaceutical sector.
Chen Wan-Shan Reports Share Transaction for Belite Bio
Chen Wan-Shan disclosed a transaction involving 13,796 shares of Belite Bio, reflecting active engagement in the pharmaceutical sector.
Clem Kerry M Reports 300,000 Stock Options in SEC Filing
Clem Kerry M, Chief Commercial Officer of OS Therapies, reports 300,000 stock options in SEC filing, highlighting executive incentives and growth potential.
OS Therapies grants stock options to director Craig Eagle
OS Therapies Inc grants 300,000 stock options to director Craig Eagle, signaling commitment to leadership incentives and aligning interests in the pharmaceutical industry.
OS Therapies grants stock options to CFO Francis Knuettel II
OS Therapies Inc has granted stock options to CFO Francis Knuettel II, highlighting its strategy to incentivize key executives in the pharmaceutical industry.
Economides Vassiliki Reports Stock Options in SEC Filing
Economides Vassiliki, CFO of Adial Pharmaceuticals, reports stock options in recent SEC filing, highlighting executive compensation in the pharmaceutical sector.
Gallotta acquires 1,459 shares under BCB Bancorp plan
Steven E. Gallotta acquires shares under BCB Bancorp's equity incentive plan, reflecting the company's strategy to attract and retain talent.
Venrock Healthcare Capital Partners XP Increases Stake in Lycia
Venrock Healthcare Capital Partners XP boosts its investment in Lycia Therapeutics, signaling confidence in the biological products sector.
SHOEN MARK V Sells 23,000 Shares of U-Haul Holding Co
SHOEN MARK V disclosed the sale of 23,000 shares of U-Haul Holding Co, impacting its ownership structure and potentially affecting the auto rental industry.
VELASCO GERMAN LARREA MOTA Acquires 400 Shares of Southern Copper
VELASCO GERMAN LARREA MOTA reports acquisition of 400 shares in Southern Copper Corp, reflecting ongoing insider activity in the metal mining sector.
SACRISTAN CARLOS RUIZ Acquires 400 Shares of Southern Copper
SACRISTAN CARLOS RUIZ reports acquisition of 400 shares in Southern Copper Corp, reflecting confidence in the metal mining sector.
Castillo Sanchez Mejorada Enrique Acquires 400 Shares
Castillo Sanchez Mejorada Enrique increases his stake in Southern Copper Corporation with the acquisition of 400 shares, totaling 1,800 shares.
Mark Hancock Sells Over 13,000 Shares of PACS Group Stock
Mark Hancock, a director at PACS Group, sells over 13,000 shares in recent transactions, indicating potential shifts in strategy within the skilled nursing care sector.
Murray Jason Hulse Sells 8,803 Shares of PACS Group, Inc.
Murray Jason Hulse reports the sale of 8,803 shares of PACS Group, Inc., reflecting strategic financial moves in the skilled nursing care industry.